MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ajo.2022.06.024

Медицинская библиотека · American journal of ophthalmology · 2022

Alternative Biologic Therapy in Children Failing Conventional TNFα Inhibitors for Refractory, Noninfectious, Chronic Anterior Uveitis.

Miraldi Utz Virginia, Angeles-Han Sheila T, Mwase Najima, Cassedy Amy, Hennard Theresa, Lovell Daniel J, Lopper Sarah, Brunner Hermine I, Dosunmu Eniolami O, Grom Alexei A, Henrickson Michael, Huggins Jennifer L, Sisk Robert A, Ting Tracy V, Kaufman Adam H

Клиническое исследованиеСтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

PURPOSE: A significant number of children with noninfectious, chronic anterior uveitis (CAU) fail to respond to conventional therapy; however, successful alternative biologic treatments (ABT) have not been well described. This study aims to review the clinical and treatment characteristics of children with CAU who require ABT.

DESIGN

Retrospective, nonrandomized clinical study.

METHODS

Setting

Tertiary center.

STUDY POPULATION: Children with noninfectious CAU.

OBSERVATION PROCEDURES: Clinical characteristics, uveitis course, complications, and treatment were compared among patients treated with methotrexate (MTX) monotherapy, conventional TNFα inhibitors (cTNFi), and ABT for >3 months.

MAIN OUTCOME MEASURE: Success of ABT (abatacept, tocilizumab, and/or golimumab) in children failing conventional treatment.

RESULTS

Of the 52 children with CAU, 75% had juvenile idiopathic arthritis. CAU was controlled in 15 children receiving MTX monotherapy, 28 receiving cTNFi, and 9 receiving ABT (n = 1, abatacept; n = 3, tocilizumab; n = 5, golimumab). Patients in the ABT group had a greater number of total ocular complications per person before ABT than those in the control groups (3.4 vs 0.7 [MTX], P < .001, and 1.5 [cTNFi], P < .001, respectively). In all 9 children on ABT, treatment led to control of CAU and topical glucocorticoids tapered to ≤2 drops/d with no new ocular complications.

CONCLUSIONS

In this study, alternative biologics (abatacept, golimumab, and tocilizumab) were useful for treating CAU in children who fail MTX and cTNFi therapy. Patients who were controlled on ABT had more disease activity, ocular complications, and anti-cTNFi neutralizing antibodies (before ABT) than those managed with conventional therapy. Larger studies are required to confirm these findings.

Для цитирования: Miraldi Utz Virginia, Angeles-Han Sheila T, Mwase Najima, Cassedy Amy, Hennard Theresa, Lovell Daniel J, Lopper Sarah, Brunner Hermine I, Dosunmu Eniolami O, Grom Alexei A, Henrickson Michael, Huggins Jennifer L, Sisk Robert A, Ting Tracy V, Kaufman Adam H. Alternative Biologic Therapy in Children Failing Conventional TNFα Inhibitors for Refractory, Noninfectious, Chronic Anterior Uveitis.. American journal of ophthalmology. 2022. DOI: 10.1016/j.ajo.2022.06.024.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.